Founded in 2016, Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing key technologies in the fields of genetic engineering and personalized medicine.

For more information, visit Canopy BioSciences or follow their updates on:



  • $4.4m
  • 30

Canopy BioSciences Articles

Canopy Biosciences Acquired by Bruker After 4 Years As BioGenerator Incubated Startup

In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

BioGenerator’s New Strategies Address St. Louis’ Talent Shortage

Augmented Intelligence Company PercayAI Partners with Canopy Biosciences to Accelerate Drug Development

Acquisition Gives St. Louis-based Canopy an International Reach

BioGenerator and Kingdom Capital Lead $2.4 Million Series A Round in Canopy BioSciences

The Agile Mission of BioGenerator’s Grants Program

New Life Science Startup Raises $2 Million